Hypopituitarism CT

Hypopituitarism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypopituitarism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypopituitarism CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypopituitarism CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypopituitarism CT
CDC on Hypopituitarism CT
Hypopituitarism CT in the news
Blogs on Hypopituitarism CT
Directions to Hospitals Treating Hypopituitarism
Risk calculators and risk factors for Hypopituitarism CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Iqra Qamar M.D.[3]

Overview

CT scan is preferred over MRI for visualization of calcification in a meningioma or a craniopharyngioma. Routine CT is insensitive to the diagnosis unless frank intracranial hemorrhage is present.The pituitary mass may be evident and be hyperdense.

CT

• CT scan is preferred over MRI for visualization of calcification in a meningioma or a craniopharyngioma
• Routine CT is insensitive to the diagnosis unless frank intracranial hemorrhage is present
• The pituitary mass may be evident and be hyperdense.
• Fluid debris levels may also be evident.

References

Template:WH Template:WS